Xiaohui He
Impact in
- Otorhinolaryngology top 0.5%
- Head and Neck Cancer Studies
-
- Lymphoma Diagnosis and Treatment
Papers in
-
- Lymphoma Diagnosis and Treatment 61
-
- Head and Neck Cancer Studies 19
- Co-authors
- Shengyu Zhou (59 shared papers)Yuankai Shi (47 shared papers)Jianliang Yang (53 shared papers)Lin Gui (54 shared papers)Liqiang Zhou (23 shared papers)Changgong Zhang (48 shared papers)Ye‐Xiong Li (10 shared papers)Shulian Wang (7 shared papers)
- Journals
- 癌症：英文版 (5 papers)Annals of Hematology (5 papers)Annals of Oncology (4 papers)International Journal of Hematology (3 papers)Blood (3 papers)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Xiaohui He
122 papers receiving 2.9k citations
Xiaohui He's Hit Papers
Peers
Comparison fields: 5 of 91
- Otorhinolaryngology 847
- Pathology and Forensic Medicine 843
- Oncology 699
- Geriatrics and Gerontology 38
- Cancer Research 62
Countries citing papers authored by Xiaohui He
This map shows the geographic impact of Xiaohui He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaohui He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaohui He more than expected).
Fields of papers citing papers by Xiaohui He
This network shows the impact of papers produced by Xiaohui He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaohui He. The network helps show where Xiaohui He may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaohui He, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 124 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Camrelizumab (SHR-1210) alone or in combination with gemcitabine plus cisplatin for nasopharyngeal carcinoma: results from two single-arm, phase 1 trials Hit paper breakdown → | 2018 | 396 |
| 2 | Camrelizumab versus placebo in combination with gemcitabine and cisplatin as first-line treatment for recurrent or metastatic nasopharyngeal carcinoma (CAPTAIN-1st): a multicentre, randomised, double-blind, phase 3 trial Hit paper breakdown → | 2021 | 334 |
| 3 | 2005 | 307 | |
| 4 | Tislelizumab plus chemotherapy as first-line treatment for recurrent or metastatic nasopharyngeal cancer: A multicenter phase 3 trial (RATIONALE-309) Hit paper breakdown → | 2023 | 157 |
| 5 | Toripalimab Plus Chemotherapy for Recurrent or Metastatic Nasopharyngeal Carcinoma Hit paper breakdown → | 2023 | 156 |
| 6 | 2021 | 79 | |
| 7 | 2008 | 71 | |
| 8 | 2019 | 69 | |
| 9 | 2019 | 50 | |
| 10 | 2016 | 45 | |
| 11 | 2021 | 43 | |
| 12 | 2020 | 41 | |
| 13 | 2023 | 38 | |
| 14 | 2020 | 35 | |
| 15 | 2020 | 35 | |
| 16 | 2013 | 33 | |
| 17 | 2019 | 33 | |
| 18 | 2016 | 32 | |
| 19 | 2012 | 31 | |
| 20 | 2021 | 31 |
About Xiaohui He
Xiaohui He is a scholar working on Pathology and Forensic Medicine, Otorhinolaryngology, Oncology, Hematology and Pulmonary and Respiratory Medicine, having authored 124 papers that have together received 2.9k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (61 papers), Head and Neck Cancer Studies (19 papers), Hematopoietic Stem Cell Transplantation (7 papers), Lung Cancer Treatments and Mutations (6 papers), Cancer Immunotherapy and Biomarkers (5 papers), Malaria Research and Control (5 papers), Thyroid Cancer Diagnosis and Treatment (4 papers) and Inflammatory Biomarkers in Disease Prognosis (3 papers). The work is most often cited by research in Otorhinolaryngology (847 citations), Pathology and Forensic Medicine (843 citations), Oncology (699 citations), Geriatrics and Gerontology (38 citations) and Cancer Research (62 citations). Xiaohui He has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Shengyu Zhou, Yuankai Shi, Jianliang Yang, Lin Gui, Liqiang Zhou, Changgong Zhang, Ye‐Xiong Li, Shulian Wang, Weihu Wang and Peng Liu. Their work appears in journals such as 癌症：英文版, Annals of Hematology, Annals of Oncology, International Journal of Hematology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.